This study is looking at new ways to screen for and diagnose cervical cancer. It's testing a new device called a multimodal optical imaging system during a colposcopy (a procedure to closely examine your cervix) for women who have had an abnormal cervical screening test. The study also compares a rapid HPV (human papillomavirus) test to other available HPV tests. The goal is to see how accurate these new methods are at finding cervical changes compared to standard lab tests. You may be able to join if you are a woman between 25 and 49 years old, have an abnormal cervical screening test, and are not pregnant or breastfeeding. The study plans to enroll 678 women.

Study design

This is a single-arm study, meaning all participants receive the same intervention, and plans to enroll 678 women. It is an interventional study, but the phase is not specified.

What's involved

You would answer a questionnaire, have a rapid urine pregnancy test, provide two self-collected cervico-vaginal samples, and have a pelvic exam with two samples taken by a healthcare provider. Imaging will take place during your colposcopy examination.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, development of the multimodal optical imaging system, will be measured through study completion, which is an average of 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.